These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32924714)

  • 21. A Review in Research Progress Concerning m6A Methylation and Immunoregulation.
    Zhang C; Fu J; Zhou Y
    Front Immunol; 2019; 10():922. PubMed ID: 31080453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
    Maity A; Das B
    FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into the roles of RNA N
    Li D; Zhu X; Li Y; Zeng X
    Chemosphere; 2020 Dec; 261():127757. PubMed ID: 32726721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ramifications of m6A Modification on ncRNAs in Cancer.
    Mehmood R
    Curr Genomics; 2024 May; 25(3):158-170. PubMed ID: 39087001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insight into the functions of N
    He Y; Du X; Chen M; Han L; Sun J
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between N
    Chen Y; Lin Y; Shu Y; He J; Gao W
    Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNAs: a new frontier in the study of human diseases.
    Shi X; Sun M; Liu H; Yao Y; Song Y
    Cancer Lett; 2013 Oct; 339(2):159-66. PubMed ID: 23791884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.
    Jacob R; Zander S; Gutschner T
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human METTL16 is a
    Warda AS; Kretschmer J; Hackert P; Lenz C; Urlaub H; Höbartner C; Sloan KE; Bohnsack MT
    EMBO Rep; 2017 Nov; 18(11):2004-2014. PubMed ID: 29051200
    [No Abstract]   [Full Text] [Related]  

  • 30. Roles of N
    Wang X; Xie H; Ying Y; Chen D; Li J
    J Cell Mol Med; 2020 Sep; 24(18):10302-10310. PubMed ID: 32808488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
    Cusenza VY; Tameni A; Neri A; Frazzi R
    Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer.
    Barros-Silva D; Lobo J; Guimarães-Teixeira C; Carneiro I; Oliveira J; Martens-Uzunova ES; Henrique R; Jerónimo C
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Long Non-coding RNAs Modified by m
    Xie SJ; Tao S; Diao LT; Li PL; Chen WC; Zhou ZG; Hu YX; Hou YR; Lei H; Xu WY; Chen WJ; Peng YW; Zhang Q; Xiao ZD
    Front Cell Dev Biol; 2021; 9():762669. PubMed ID: 34722547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epitranscriptome of long noncoding RNAs in metabolic diseases.
    Yin L; Zhu X; Novák P; Zhou L; Gao L; Yang M; Zhao G; Yin K
    Clin Chim Acta; 2021 Apr; 515():80-89. PubMed ID: 33422492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YTH Domain: A Family of N
    Liao S; Sun H; Xu C
    Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):99-107. PubMed ID: 29715522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of N6-methyladenosine-modified non-coding RNAs in different disorders.
    Ghafouri-Fard S; Shoorei H; Hussen BM; Dong P; Zhai T; Taheri M; Samadian M
    Eur J Pharmacol; 2023 May; 946():175644. PubMed ID: 36921707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Important Role of N6-methyladenosine RNA Modification in Non-Small Cell Lung Cancer.
    Cheng Y; Wang M; Zhou J; Dong H; Wang S; Xu H
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33808751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and functional analysis of N6-methyladenine (m
    Xu D; Xu Z; Bi X; Cai J; Cao M; Zheng D; Chen L; Li P; Wang H; Wu D; Yang J; Li K
    Cancer Med; 2023 Jan; 12(2):2104-2116. PubMed ID: 35789547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.